Computational discovery of novel trypanosomicidal drug-like chemicals by using bond-based non-stochastic and stochastic quadratic maps and linear discriminant analysis

被引:24
作者
Alberto Castillo-Garit, Juan [1 ,2 ,3 ]
Vega, Maria C. [4 ]
Rolon, Miriam [4 ]
Marrero-Ponce, Yovani [2 ,3 ,5 ]
Kouznetsov, Vladimir V. [6 ]
Amado Torres, Diego Fernando [6 ]
Gomez-Barrio, Alicia [4 ]
Alvarez Bello, Alfredo [2 ]
Montero, Alina [2 ]
Torrens, Francisco [3 ]
Perez-Gimenez, Facundo [5 ]
机构
[1] Cent Univ Las Villas, Fac Chem Pharm, Appl Chem Res Ctr, Santa Clara 54830, Villa Clara, Cuba
[2] Cent Univ Las Villas, Fac Chem Pharm, Unit Comp Aided Mol Biosilico Discovery & Bioinfo, CAMD BIR Unit, Santa Clara 54830, Villa Clara, Cuba
[3] Univ Valencia, Inst Univ Ciencia Mol, E-46071 Valencia, Spain
[4] UCM, Fac Farm, Dept Parasitol, Madrid 28040, Spain
[5] Univ Valencia, Fac Farm, Dept Quim Fis, Unidad Invest Diseno Farm & Conectividad Mol, E-46003 Valencia, Spain
[6] Univ Ind Santander, Escuela Quim, Lab Quim Organ & Biomol, Bucaramanga, Colombia
关键词
TOMOCOMD-CARDD software; Bond-based quadratic indices; LDA-assisted QSAR model; Virtual screening; Trypanosomicidal; Cytotoxicity; ATOM-ADJACENCY MATRIX; IN-SILICO; TRYPANOTHIONE REDUCTASE; BILINEAR INDEXES; TYROSINASE INHIBITORS; RATIONAL DESIGN; CHAGAS-DISEASE; CRUZI; DERIVATIVES; PREDICTION;
D O I
10.1016/j.ejps.2009.10.007
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Herein we present results of a quantitative structure-activity relationship (QSAR) studies to classify and design, in a rational way, new anti trypanosomal compounds by using non-stochastic and stochastic bond-based quadratic indices. A data set of 440 organic chemicals, 143 with anti trypanosomal activity and 297 having other clinical uses, is used to develop QSAR models based on linear discriminant analysis (LDA). Non-stochastic model correctly classifies more than 93% and 95% of chemicals in both training and external prediction groups, respectively. On the other hand, the stochastic model shows an accuracy of about the 87% for both series. As an experiment of virtual lead generation, the present approach is finally satisfactorily applied to the virtual evaluation of 9 already synthesized in house compounds. The in vitro anti trypanosomal activity of this series against epimastigote forms of Trypanosoma cruzi is assayed. The model is able to predict correctly the behaviour for the majority of these Compounds. Four compounds (FER16, FER32, FER33 and FER 132) showed more than 70% of epimastigote inhibition at a concentration of 100 mu g/mL (86.74%, 78.12%, 88.85% and 72.10%, respectively) and two of these chemicals, FER16 (78.22% of AE) and FER33 (81.31% of AE), also showed good activity at a concentration of 10 mu g/mL. At the same concentration, compound FER16 showed lower value of cytotoxicity (15.44%), and compound FER33 showed very low value of 1.37%. Taking into account all these results, we can say that these three compounds can be optimized in forthcoming works, but we consider that compound FER33 is the best candidate. Even though none of them resulted more active than Nifurtimox, the current results constitute a step forward in the search for efficient ways to discover new lead antitrypanosomals. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:30 / 36
页数:7
相关论文
共 69 条
[1]
Novel antiprotozoal products:: Imidazole and benzimidazole N-oxide derivatives and related compounds [J].
Aguirre, G ;
Bolani, M ;
Cerecetto, H ;
Gerpe, A ;
González, M ;
Sainz, YF ;
Denicola, A ;
de Ocáriz, CO ;
Nogal, JJ ;
Montero, D ;
Escario, JA .
ARCHIV DER PHARMAZIE, 2004, 337 (05) :259-270
[2]
SPECIFIC CHEMOTHERAPY OF CHAGAS-DISEASE - A COMPARISON BETWEEN THE RESPONSE IN PATIENTS AND EXPERIMENTAL-ANIMALS INOCULATED WITH THE SAME STRAINS [J].
ANDRADE, SG ;
RASSI, A ;
MAGALHAES, JB ;
FILHO, FF ;
LUQUETTI, AO .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1992, 86 (06) :624-626
[3]
[Anonymous], 2007, ORGANIC CHEM DRUGS T
[4]
[Anonymous], 1996, MERCK INDEX, V12th
[5]
[Anonymous], MOLECULES
[6]
Prolylisoxazoles: Potent inhibitors of prolyloligopeptidase with antitrypanosomal activity [J].
Bal, G ;
Van der Veken, P ;
Antonov, D ;
Lambeir, AM ;
Grellier, P ;
Croft, SL ;
Augustyns, K ;
Haemers, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (17) :2875-2878
[7]
Assessing the accuracy of prediction algorithms for classification: an overview [J].
Baldi, P ;
Brunak, S ;
Chauvin, Y ;
Andersen, CAF ;
Nielsen, H .
BIOINFORMATICS, 2000, 16 (05) :412-424
[8]
Inhibition of Trypanosoma cruzi trypanothione reductase by acridines:: Kinetic studies and structure-activity relationships [J].
Bonse, S ;
Santelli-Rouvier, C ;
Barbe, J ;
Krauth-Siegel, RL .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) :5448-5454
[9]
A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents [J].
Buckner, F ;
Yokoyama, K ;
Lockman, J ;
Aikenhead, K ;
Ohkanda, J ;
Sadilek, M ;
Sebti, S ;
Van Voorhis, W ;
Hamilton, A ;
Gelb, MH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (25) :15149-15153
[10]
Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors [J].
Buckner, FS ;
Griffin, JH ;
Wilson, AJ ;
Van Voorhis, WC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1210-1215